6533b828fe1ef96bd1288fe5

RESEARCH PRODUCT

Characterization of Metabolically Healthy Obese People and Metabolically Unhealthy Normal-Weight People in a General Population Cohort of the ABCD Study.

Valentina SettipaniGiuseppe RosafioMaria Fatima MassentiDavide CorleoCarla GiordanoLoretta CosentinoSilvio BuscemiCarola BuscemiAnna Maria BarilePierfilippo ChiarelloVincenza Maniaci

subject

GerontologyMaleEndocrinology Diabetes and Metabolism; EndocrinologyEndocrinology Diabetes and MetabolismIdeal Body Weight030204 cardiovascular system & hematologylcsh:Diseases of the endocrine glands. Clinical endocrinologySettore MED/13 - EndocrinologiaBody Mass IndexCohort Studies0302 clinical medicineEndocrinologyLongitudinal StudiesSettore MED/49 - Scienze Tecniche Dietetiche ApplicateYoung adultAged 80 and overMiddle AgedItalyCohortHypertensionFemaleCohort studyResearch ArticleAdultmedicine.medical_specialtyArticle SubjectAdolescentGeneral Population Cohort030209 endocrinology & metabolismPrediabetic State03 medical and health sciencesYoung AdultMetabolic DiseasesDiabetes mellitusInternal medicinemedicineHumansObesityAgedObesity Metabolically Benignlcsh:RC648-665business.industrynutritional and metabolic diseasesOverweightmedicine.diseaseObesityDiabetes Mellitus Type 2Observational studybusinessBody mass index

description

There is actually no consensus about the possibility that in some instances, obesity may be a benign metabolically healthy (MH) condition as opposed to a normal-weight but metabolically unhealthy (MUH) state. The aim of this study was to characterize MH condition and to investigate possible associations with metabolic and cardiovascular complications. One thousand nineteen people (range of age 18–90 years) of the cohort of the ABCD_2 study were investigated. Participants were classified as normal weight (BMI < 24.9 kg/m2) or overweight-obese (BMI ≥25 kg/m2); they were also classified as MH in the presence of 0-1 among the following conditions: (a) prediabetes/type 2 diabetes, (b) hypertension, (c) hypertriglyceridemia or low HDL cholesterolemia, and (d) hypercholesterolemia. MUH condition was diagnosed if ≥2 of the conditions listed were found. The prevalence of overweight/obese people was 71.1%, of whom 27.4% were found to be MH. In addition, 36.7% of the normal-weight participants were MUH. HOMA-IR, high sensitivity C-reactive protein, and the carotid intima-media thickness were significantly different in the 4 subgroups (P<0.001), with higher values observed in the MUH normal-weight and obese groups. In conclusion, this study highlights the importance of identifying a MH condition in normal-weight and in obese people in order to offer better treatment.

10.1155/2017/9294038https://pubmed.ncbi.nlm.nih.gov/28840131